AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million

AstraZeneca said on Tuesday it would sell rights to its cholesterol drug, Crestor, to German pharmaceutical company Grünenthal GmbH for an upfront payment of $320 million.

from Top Business News- News18.com https://ift.tt/2Vjp9Zt